Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Article :102104

    
• • ·Corrigendum to “Presence and function of ?-adrenergic receptors in primary equine bronchial epithelia cells” [Pulm Pharmacol Ther. (2020 Apr) 61 101897] DOI: 10.1016/j.pupt.2020.101897

    Article :102093

    Linda Marie Schellenberg, Jana Bonicelli, Ina Hochheim, Ralf Regenthal, Getu Abraham

    

• Review Articles

  • ·“The possible implication of endothelin in the pathology of COVID-19-induced pulmonary hypertension”

    Article :102082

    Omnia Azmy Nabeh, Lamiaa Mohammed Matter, Mahmoud Ahmed Khattab

    Résumé Résumé Plan Plan  
  • ·Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis

    Article :102081

    Woon Hean Chong, Kurt Hu, Biplab K. Saha, Amit Chopra

    Résumé Résumé Plan Plan   
  • ·The immunomodulatory effects of macrolide antibiotics in respiratory disease

    Article :102095

    Jennifer Pollock, James D. Chalmers

    Résumé Résumé Plan Plan  

• Original Articles

  • ·Effect of centrally and peripherally acting GABA_B agonism on the healthy human cough reflex

    Article :102079

    Huda Badri, Carmen LGibbard, Dimitra Denton, Imran Satia, Rachel J. Dockry, Kimberley Holt, Jane Escott, Greame Wilkinson, Alison Holt, Brendan J. Canning, Jacky A. Smith

    Résumé Résumé Plan Plan  
  • ·Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps

    Article :102080

    Rui Zhu, Ryan Owen, Justin Wilkins, Rik Schoemaker, Xianbin Tian, Aurelie Gautier, Gaohong She, Shweta Vadhavkar, Melissa Cheu, Kit Wong, Theodore A. Omachi, Wendy S. Putnam, Angelica L. Quartino

    Résumé Résumé Plan Plan   
  • ·Enlightening clinical and therapeutic heterogeneity in thoracic actinomycosis: A review in bronchiectasis and non-bronchiectasis patients

    Article :102078

    Catarina Gouveia Cardoso, Cláudia Freitas, Isabel Gomes, Adriana Magalhães, Gabriela Fernandes, Susana Guimarães, Natália Cruz-Martins, Adelina Amorim, Patrícia Caetano Mota

    Résumé Résumé Plan Plan  
  • ·The ALPACA study: (In)Appropriate LAMA prescribing in asthma: A cohort analysis

    Article :102074

    E.J. Baan, C.E. Hoeve, M. De Ridder, L. Demoen, L. Lahousse, G.G. Brusselle, K.M.C. Verhamme

    Résumé Résumé Plan Plan   
  • ·Which LABA/LAMA should be chosen in COPD patients in real life?

    Article :102076

    Bruno Sposato, Elisa Petrucci, Andrea Serafini, Fabio Lena, Leonardo Gianluca Lacerenza, Andrea Montagnani, Massimo Alessandri, Alberto Cresti, Raffaele Scala, Paola Rogliani, Alberto Ricci, Antonio Perrella, Marco Scalese

    Résumé Résumé Plan Plan  
  • ·Effectiveness of inhalation technique assessment service for patients with Respimat® inhaler

    Article :102077

    Vilma Rossi, Johanna Salimäki, Charlotta Sandler, Marja Airaksinen, Paula Kauppi

    Résumé Résumé Plan Plan   
  • ·Leukotriene inhibition and the risk of lung cancer among U.S. veterans with asthma

    Article :102084

    S. Scott Sutton, Joseph Magagnoli, Tammy H. Cummings, James W. Hardin

    Résumé Résumé Plan Plan  
  • ·HDAC8-inhibitor PCI-34051-induced exosomes inhibit human bronchial smooth muscle cell proliferation via miR-381-3p mediated TGFB3

    Article :102096

    Shi-Yao Bai, Meng-Lu Li, Yuan Ren, Xin-Ming Su

    Résumé Résumé Plan Plan   
  • ·Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis

    Article :102099

    Aykut Cilli, Fatih Uzer, Can Sevinç, Funda Co?kun, Ahmet Ursava?, ?ükriye Öner, F?rat Kose

    Résumé Résumé Plan Plan